Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Dilutive issuance
confidence 92%
filed 2026-06-01
Item 3.02
The Company issued 142,800 shares of common stock in exchange for preferred stock held by an existing investor, relying on Section 3(a)(9) of the Securities Act. This is an unregistered equity issuance that increases the common share count and dilutes existing shareholders. Although structured as a preferred-for-common exchange with no cash proceeds, the material increase in common shares outstanding and the unregistered nature of the issuance make this a dilutive equity event material to investors assessing ownership and voting power.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-01
Item 1.01
The filing discloses entry into material definitive agreements governing a commercial mortgage securitization transaction. The Pooling and Servicing Agreement dated March 1, 2026, between BMO Commercial Mortgage Securities LLC (depositor), Midland Loan Services (master servicer), CWCapital Asset Management LLC (special servicer), and other parties, governs the issuance of the BMO 2026-5C14 Mortgage Trust Certificates on March 25, 2026. Additionally, the filing describes the subsequent transfer of the Compass Storage National Portfolio Whole Loan to the Benchmark 2026-V22 Securitization on May 26, 2026, governed by a separate Pooling and Servicing Agreement. These are material securitization transactions involving the pooling and transfer of mortgage loans, which constitute material acquisition and disposition activity typical of Item 1.01 disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-01
Item 2.02
The filing discloses Science Applications International Corporation's financial results for the first fiscal quarter ended May 1, 2026, via a press release furnished as Exhibit 99.1. The company is hosting an earnings conference call to discuss operations and financial results. This is a standard quarterly earnings release disclosure under Item 2.02, which is material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-01
Item 2.01
Braemar Hotels completed the sale of Park Hyatt Beaver Creek Resort & Spa for $176 million in cash on May 26, 2026, with net proceeds of approximately $104.5 million after repayment of a $70.5 million mortgage. The company used proceeds from this material asset disposition to repay approximately $86.25 million in convertible senior notes at their scheduled maturity on June 1, 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-01
Item 5.07
This 8-K Item 5.07 discloses the results of USA TODAY Co.'s Annual Meeting of Stockholders held on June 1, 2026, including voting outcomes on five proposals: election of eight directors, ratification of Grant Thornton LLP as independent auditor, advisory approval of executive compensation, and three failed proposals to amend the Charter and Bylaws regarding supermajority voting requirements. The detailed vote tallies for each proposal are the core disclosure, making this a textbook shareholder_vote_results event that is material to investors assessing governance and board composition.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-01
Item 8.01
Summit Therapeutics disclosed results from two clinical trials (AK112-206 Phase II and HARMONi-6 Phase III) for ivonescimab in colorectal cancer via press releases and a scheduled investor conference call. While this represents material clinical trial data that would affect investor assessment of the company's pipeline, it does not fit the specific "earnings_release" category (which typically refers to financial results) nor any other more specific event type. This is a material clinical development disclosure appropriately classified as other_material.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-01
Item 3.02
While Item 3.02 addresses unregistered equity issuances, the core disclosure centers on entry into a merger agreement with NCS Multistage Holdings, Inc., with Weatherford acquiring the target through a merger structure. The equity issuance (up to 818,604 Ordinary Shares to Advent) is incidental to the material acquisition transaction. This is a change-of-control event expected to close in Q3 2026, which is material to investors.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-01
Item 8.01
Via Renewables announced the redemption of 1,884,935 shares of Series A Preferred Stock at $25.00 per share (approximately $47.1 million in principal), representing a material capital transaction. While redemptions of preferred stock are routine corporate actions, the magnitude and the fact that it is disclosed in an 8-K Item 8.01 indicates the company views it as material to investors. This does not fit neatly into the more specific event categories (not M&A, not an impairment, not a covenant breach), making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-01
Item 5.07
This is a clear disclosure of shareholder voting results from Sunrun's Annual Meeting of Stockholders held on May 28, 2026. The filing reports the outcomes of three proposals: election of nine directors, advisory vote on named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. All three proposals passed with substantial majorities, and the specific vote tallies for each director and proposal are provided, which is the hallmark of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-01
Item 8.01
Public Storage disclosed an operating update for same-store facilities covering April 1 through May 28, 2026 and 2025, including key metrics such as average annual contract rent per square foot, churn rates, and occupancy levels, constituting a material event affecting investor assessment of the company's business performance and trends.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-01
Item 5.02
Silvio Napoli was appointed as Chief Executive Officer of Lucid Group, Inc., effective June 1, 2026. Marc Winterhoff resumed the role of Chief Operating Officer as part of the leadership restructuring.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-01
Item 1.01
Wheels Up entered into a $100 million unsecured term loan credit agreement on May 29, 2026, with existing lenders Delta, Cox, and CK Wheels, with potential for an additional $100 million in incremental commitments. The facility amends the existing 2023 Credit Agreement and will fund working capital, growth initiatives, fleet expansion, and debt repayment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-01
Item 5.02
While the disclosure centers on Jerry Morton's retirement effective December 31, 2026, the principal action disclosed is the appointment of Mark Klossner as Executive Vice President & President, Industrial Powertrain Solutions, effective June 1, 2026. The filing emphasizes Klossner's appointment and his transition into the role, making this an executive appointment event. The retirement is contextual to the succession plan rather than the primary focus.
View raw filing on EDGAR →
8-K
Covenant Breach
confidence 85%
filed 2026-06-01
Item 1.01
Inotiv failed to make a required interest payment of $2.139 million on its Convertible Notes due April 15, 2026, and has negotiated successive extensions of the grace period (from 30 to 44 to 51 days) with noteholders. This constitutes a covenant breach—a triggering event that accelerates or increases a direct financial obligation, with the imminent risk of default if payment is not made by June 5, 2026.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-01
Item 8.01
Strive is announcing a material expansion of its at-the-market (ATM) programs, increasing the maximum aggregate offering size by $2.1 billion across two securities (Class A common stock and SATA Stock). The filing explicitly acknowledges "dilution caused by Strive's issuance of additional shares" as a forward-looking risk factor, and ATM programs represent unregistered or registered continuous equity issuances that can dilute existing shareholders. This is a material capital-raising activity that would affect investor assessment of ownership dilution and future financing capacity.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-06-01
Item 5.02
Jason L. Groves, the Chief Legal Officer & Corporate Secretary, tendered his resignation effective May 29, 2026. While the disclosure includes severance terms (one month base salary), the principal disclosed action is the departure of a named executive officer from a material role. The filing explicitly states the departure was not due to disagreement or operational issues, and the company is conducting a search for a permanent replacement, confirming this is a straightforward executive departure rather than a compensation arrangement or appointment.
View raw filing on EDGAR →
8-K
Going Concern
confidence 95%
filed 2026-06-01
Item 8.01
The filing explicitly discloses that GoPro's refiled consolidated financial statements now include an updated Note 1 stating "there is substantial doubt about the Company's ability to continue as a going concern," with PricewaterhouseCoopers LLP's audit report including an explanatory paragraph on this matter. This is the primary material event disclosed in Item 8.01, and the going-concern language is unmistakable and directly stated.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-01
Item 2.02
The filing discloses a Quarterly Shareholder Report issued on May 28, 2026, containing "abbreviated financial and operating results for the quarter ended April 4, 2026" attached as Exhibit 99.1. This is a classic earnings release disclosure under Item 2.02, providing quarterly financial results to shareholders and the market.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 85%
filed 2026-06-01
Item 8.01
The disclosure describes a Nasdaq compliance notice under Listing Rule 5250(c)(1) for failure to meet periodic filing requirements, followed by notification of regained compliance. While the matter was resolved, the initial non-compliance notice and delisting risk trigger material disclosure obligations. The company's ability to maintain listing is a material concern to investors, even though compliance was subsequently restored.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-01
Item 5.02
Dr. Joshua Ofman was appointed as Chief Executive Officer of GRAIL, Inc., effective June 1, 2026. The appointment includes compensatory arrangements comprising a base salary of $800,000, an RSU grant of $2,000,000, and severance provisions.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-01
Item 3.03
Samsara Inc. completed a reincorporation from Delaware to Nevada effective June 1, 2026, materially modifying shareholder rights by changing the governing law and corporate governance documents. The reincorporation fundamentally altered the legal framework governing the company and its shareholders, as detailed in an Information Statement filed May 11, 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-01
Item 5.07
This 8-K Item 5.07 discloses the results of Neptune Insurance's 2026 Annual Meeting of Stockholders held on May 28, 2026, including voting outcomes for two proposals: election of two Class I directors (Trevor Burgess and Jonathan Carlon) and ratification of PricewaterhouseCoopers LLP as independent auditors. The filing presents detailed vote tallies (For, Against/Withhold, Abstain, Broker Non-Vote) for each matter, which is the core disclosure required under Item 5.07 for shareholder meeting results.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-01
Item 2.02
Credo Technology Group disclosed financial results for the fiscal year ended May 2, 2026, via a press release furnished as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-01
Item 5.02
The Board approved a special performance-based equity award of 1,437,000 ordinary shares in restricted stock units for CEO William Brennan under the 2021 Long-Term Incentive Plan, with six tranches tied to revenue and stock price hurdles over a five-year performance period.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-01
Item 5.07
This is a clear disclosure of shareholder voting results from the May 27, 2026 Annual Meeting of Stockholders, covering three proposals: election of two Class II directors (William S. Benjamin and Caroline E. Blakely), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents final vote tallies for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-01
Item 1.01
V2X entered into Amendment No. 6 to its First Lien Credit Agreement on May 29, 2026, providing for approximately $868.5 million in new term loans that refinance all existing term loans, with maturity in 2030. This substantial debt restructuring constitutes a material change in the registrant's capital structure and financial obligations.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-01
Item 5.07
This is a clear disclosure of shareholder vote results from Axon Enterprise's 2026 Annual Meeting of Shareholders held on May 28, 2026. The filing reports voting outcomes for three proposals: election of nine directors, advisory approval of named executive officer compensation ("Say-on-Pay"), and ratification of PricewaterhouseCoopers LLP as independent auditor. The detailed vote tallies (FOR, AGAINST, WITHHELD/ABSTAIN, and broker non-votes) for each matter are the hallmark of Item 5.07 disclosures and are material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-01
Item 5.07
Esperion held its Annual Meeting of Stockholders on May 28, 2026, with shareholders voting on four proposals: election of two Class I directors (J. Martin Carroll and Sheldon L. Koenig), an advisory vote on named executive officer compensation, ratification of Ernst & Young LLP as auditor, and approval of a 7,000,000 share increase to the 2022 Stock Option and Incentive Plan. Vote tallies for each proposal are disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-01
Item 5.07
This is a clear disclosure of shareholder voting results from Black Rock Coffee Bar's Annual Meeting of Shareholders held on May 27, 2026. The filing reports the election of two Class I directors (Jeff Hernandez and Kristina Cashman) and ratification of Deloitte & Touche LLP as independent auditor, with detailed vote tallies for each proposal. This is the quintessential Item 5.07 disclosure and is material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-01
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from the May 29, 2026 Annual Meeting. The filing reports voting outcomes on four proposals: election of three Class I directors (Gabe Finke, Marian Joh, Matthew Kuta), ratification of PricewaterhouseCoopers LLP as independent auditor, approval of redomestication from Delaware to Texas, and adjournment authority. The redomestication approval is particularly material as it represents a significant corporate restructuring expected to become effective June 15, 2026.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-01
Item 8.01
The Amendment expands the Field of the SPY003 License Agreement from inflammatory bowel disease to all therapeutic uses, subject to time-based dosing restrictions. This materially broadens the Company's development rights and commercial potential for SPY003, affecting the scope of its pipeline and strategic optionality. While not a traditional M&A, restatement, or executive event, the expansion of licensed rights and removal of field restrictions is material to investors assessing the registrant's asset base and development strategy.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-01
Item 1.01
HPE amended its cooperation agreement with Elliott Investment Management to constrain board size to 14 directors through the 2027 Annual Meeting, modifying governance and board composition restrictions.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-01
Item 2.02
HPE issued a press release disclosing financial results for its fiscal quarter ended April 30, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-01
Item 5.02
Christopher P. Hsu was appointed to the Board of Directors and two Board committees (Strategy Committee and Finance and Investment Committee) effective immediately pursuant to the Cooperation Agreement with Elliott Investment Management.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-01
Item 7.01
HPE closed the sale of 5.2% of H3C Technologies Co., Limited for approximately USD $370.4 million on May 28, 2026, pursuant to a previously disclosed Share Purchase Agreement.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-01
Item 5.02
The filing discloses the appointment of Nate Olmstead as Chief Financial Officer, effective July 9, 2026, replacing interim CFO Tahnil Davis. While the disclosure includes compensatory details (base salary of $600,000, target bonus of $600,000, signing bonus of $600,000, and $10.0 million in equity grants), the principal disclosed action is the appointment of a named executive officer to a material position. This is a classic exec_appointment event, material to investors as CFO changes affect financial oversight and strategy.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-06-01
Item 5.02
Alex V. Volkov resigned from ProPetro's Board of Directors on May 28, 2026, reducing the Board size from eight to seven directors. While the resignation was triggered by Pioneer's sale of all remaining shares and was not due to disagreement, the core disclosed action is a director's departure from the Board, which is material to investors as it affects Board composition and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-01
Item 5.02
Eric Mullins was elected to the Board of Directors of TechnipFMC plc effective June 1, 2026, and appointed to the Audit Committee. The Board size increased from nine to ten directors.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-01
Item 1.01
CitroTech entered into Stock Exchange and Stockholders Agreements on May 28, 2026, involving a material recapitalization whereby the Company reacquired 1,666,667 shares of Series A Preferred Stock and issued 103,558 shares of Series C Preferred Stock to BRH with an additional 467,012 shares committed to TCSI. The transaction eliminates all Series A Preferred Stock, restructures the capital structure, grants board designation and registration rights, and constitutes a material change of control.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-01
Item 1.01
Lantronix entered into an underwriting agreement on May 29, 2026, to sell 4,166,667 shares of common stock at $7.20 per share, with underwriters exercising a full 30-day option for an additional 625,000 shares, generating approximately $32.3 million in net proceeds. This registered public offering materially dilutes existing shareholders' ownership and represents a significant capital-raising event for the company.
View raw filing on EDGAR →
8-K
Other material
confidence 85%
filed 2026-06-01
Item 8.01
The disclosure reports that the Phase 2/3 POWER1 study of vormatrigine failed to meet its primary success measure in focal onset seizures, though secondary measures were met. The Company is pausing enrollment in the POWER2 study to reassess the program. For a clinical-stage biopharmaceutical company, a failed primary endpoint in a pivotal Phase 2/3 trial represents a material setback to a key development program that would significantly affect investor assessment of the company's pipeline and prospects. This does not fit neatly into the specific event categories (not a restatement, impairment, or litigation), making "other_material" the appropriate classification.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 85%
filed 2026-06-01
Item 7.01
Exicure received a notification from Nasdaq's Listing Qualifications Department indicating non-compliance with Nasdaq Listing Rule 5250(c)(1) due to delayed filing of its Form 10-Q. Although the company states it has since regained compliance by filing the 10-Q on May 29, 2026, the receipt of a listing compliance notice is a material delisting risk event that would affect a reasonable investor's assessment of the company's continued listing status.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-01
Item 5.07
This Item 5.07 discloses the results of Northwest Natural Holding Company's Annual Meeting of Shareholders held on May 28, 2026, including voting outcomes on three proposals: election of three Class III directors (David H. Anderson, Peter J. Bragdon, Nathan I. Partain), advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. The disclosure includes vote tallies (FOR, AGAINST, ABSTAIN, and broker non-votes) for each proposal, which is the standard format for shareholder vote results required under Item 5.07.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-01
Item 5.02
James Jeffery Raborn was appointed to Charlotte's Web Holdings' board of directors effective May 28, 2026, as a designee of British American Tobacco pursuant to an amended Investor Rights Agreement.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-01
Item 5.07
Charlotte's Web Holdings held its annual general and special meeting on May 28, 2026, with shareholders voting on four proposals: setting board size at six directors, electing six directors, appointing PKF O'Connor Davies LLP as auditors, and approving a material transaction involving amendment of a C$75.3M convertible debenture held by BAT and issuance of greater than 25% of outstanding shares, which would create a new control person.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-01
Item 8.01
Charlotte's Web Holdings closed a material transaction with British American Tobacco (BT DE Investments Inc.) on May 28, 2026, involving amendment of a C$75.3M convertible debenture and issuance of greater than 25% of outstanding shares, creating a new control person.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-01
Item 8.01
Immuneering announced updated Phase 2a clinical trial data for atebimetinib in pancreatic cancer showing a 17.3-month median overall survival versus 8.5 months for standard of care, along with a 36% overall response rate and 82% disease control rate. While this is a clinical trial update rather than a formal earnings release or other specifically enumerated event type, the positive efficacy and safety data for a lead product candidate in a pivotal development stage would materially affect investor assessment of the company's prospects, particularly given the announced Phase 3 trial initiation expected in mid-2026.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-01
Item 3.02
StepStone Group completed an unregistered sale of equity securities as part of the 2026 Exchange transaction, issuing approximately 972,685 shares of Class A Common Stock and 2,438,273 Class D Units to acquire additional equity interests in three Asset Class Entities.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-01
Item 1.01
System1 entered into a comprehensive debt exchange and settlement agreement on May 29, 2026, whereby the company exchanges approximately $150 million in existing term loans, $39.3 million in Series A Preferred Stock, and $31.4 million in cash consideration for the repayment and termination of all outstanding loans and revolving commitments. The transaction fundamentally restructures the company's capital structure, involves significant equity issuance (39,250 preferred shares representing ~27.4% dilution on an as-converted basis), and requires stockholder approval under NYSE rules.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-01
Item 5.07
This is a clear disclosure of shareholder vote results from Energy Vault's Annual Meeting of Stockholders held on May 29, 2026, covering the election of Class II Directors (Stephanie Unwin, Theresa Fariello, and Thomas Ertel) and ratification of BDO USA, P.C. as independent auditor. Item 5.07 is the designated 8-K item for shareholder vote results, and the filing presents tabulated voting outcomes with votes for, against/withheld, and broker non-votes.
View raw filing on EDGAR →